142 related articles for article (PubMed ID: 33617471)
21. Development of an E2 ELISA Methodology to Assess Chikungunya Seroprevalence in Patients from an Endemic Region of Mexico.
Kim YC; López-Camacho C; Garcia-Larragoiti N; Cano-Mendez A; Hernandez-Flores KG; Domínguez-Alemán CA; Mar MA; Vivanco-Cid H; Viveros-Sandoval ME; Reyes-Sandoval A
Viruses; 2019 May; 11(5):. PubMed ID: 31052472
[TBL] [Abstract][Full Text] [Related]
22. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients.
Patil HP; Rane PS; Shrivastava S; Palkar S; Lalwani S; Mishra AC; Arankalle VA
Viral Immunol; 2021 Apr; 34(3):201-209. PubMed ID: 33656935
[TBL] [Abstract][Full Text] [Related]
23. Estimating the seroprevalence of chikungunya virus exposure in Shimoga district, Karnataka state: A hospital-based study during 2014-2018.
Shilpa C; Kavitha K; Sudheesh N; Sabeena S; Prasad V; Hindol M; Arunkumar G
J Med Virol; 2020 Jan; 92(1):119-123. PubMed ID: 31463940
[TBL] [Abstract][Full Text] [Related]
24. A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam S; Nyo M; Phuektes P; Yew CW; Tan YJ; Chu JJ
MAbs; 2015; 7(6):1178-94. PubMed ID: 26305993
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic potential of monoclonal antibodies against the capsid protein of chikungunya virus for detection of recent infection.
Damle RG; Jayaram N; Kulkarni SM; Nigade K; Khutwad K; Gosavi S; Parashar D
Arch Virol; 2016 Jun; 161(6):1611-22. PubMed ID: 27016930
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence and clinical manifestations of chikungunya virus infection in rural areas of Chandrapur, Maharashtra, India.
Kawle AP; Nayak AR; Bhullar SS; Borkar SR; Patankar SD; Daginawala HF; Singh LR; Kashyap RS
J Vector Borne Dis; 2017; 54(1):35-43. PubMed ID: 28352044
[TBL] [Abstract][Full Text] [Related]
27. Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand.
Nitatpattana N; Kanjanopas K; Yoksan S; Satimai W; Vongba N; Langdatsuwan S; Nakgoi K; Ratchakum S; Wauquier N; Souris M; Auewarakul P; Gonzalez JP
Virol J; 2014 Oct; 11():183. PubMed ID: 25330992
[TBL] [Abstract][Full Text] [Related]
28. Chikungunya Outbreaks in India: A Prospective Study Comparing Neutralization and Sequelae during Two Outbreaks in 2010 and 2016.
Jain J; Kaur N; Haller SL; Kumar A; Rossi SL; Narayanan V; Kumar D; Gaind R; Weaver SC; Auguste AJ; Sunil S
Am J Trop Med Hyg; 2020 Apr; 102(4):857-868. PubMed ID: 32067624
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.
Kashyap RS; Morey SH; Ramteke SS; Chandak NH; Parida M; Deshpande PS; Purohit HJ; Taori GM; Daginawala HF
Clin Vaccine Immunol; 2010 Feb; 17(2):291-7. PubMed ID: 20007365
[TBL] [Abstract][Full Text] [Related]
30. Retrospective investigation of antibodies against chikungunya virus (CHIKV) in serum from febrile patients in Mozambique, 2009-2015: Implications for its prevention and control.
Antonio VS; Amade NA; Muianga AF; Ali S; Monteiro V; Mula F; Chelene I; Oludele J; Chongo I; José A; Augusto O; Gudo ES
PLoS One; 2019; 14(3):e0213941. PubMed ID: 30897135
[TBL] [Abstract][Full Text] [Related]
31. Antigenic Variation of East/Central/South African and Asian Chikungunya Virus Genotypes in Neutralization by Immune Sera.
Chua CL; Sam IC; Merits A; Chan YF
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004960. PubMed ID: 27571254
[TBL] [Abstract][Full Text] [Related]
32. Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.
Auerswald H; Boussioux C; In S; Mao S; Ong S; Huy R; Leang R; Chan M; Duong V; Ly S; Tarantola A; Dussart P
Emerg Microbes Infect; 2018 Feb; 7(1):13. PubMed ID: 29410416
[TBL] [Abstract][Full Text] [Related]
33. Anti-chikungunya virus seroprevalence in Indigenous groups in the São Francisco Valley, Brazil.
Nicacio JM; Khouri R; da Silva AML; Barral-Netto M; Lima JAC; Ladeia AMT; do Carmo RF; Armstrong ADC
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009468. PubMed ID: 34181663
[TBL] [Abstract][Full Text] [Related]
34. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort.
Yoon IK; Srikiatkhachorn A; Alera MT; Fernandez S; Cummings DAT; Salje H
Int J Infect Dis; 2020 Jun; 95():167-173. PubMed ID: 32247051
[TBL] [Abstract][Full Text] [Related]
35. Detection of Chikungunya Virus in Nepal.
Pandey BD; Neupane B; Pandey K; Tun MM; Morita K
Am J Trop Med Hyg; 2015 Oct; 93(4):697-700. PubMed ID: 26195462
[TBL] [Abstract][Full Text] [Related]
36. Characterization of antibody response in patients with acute and chronic chikungunya virus disease.
Anfasa F; Lim SM; Fekken S; Wever R; Osterhaus ADME; Martina BEE
J Clin Virol; 2019 Aug; 117():68-72. PubMed ID: 31229935
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of antibodies against chikungunya virus in Singapore resident adult population.
Ang LW; Kam YW; Lin C; Krishnan PU; Tay J; Ng LC; James L; Lee VJM; Goh KT; Ng LFP; Lin RTP
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006163. PubMed ID: 29281644
[TBL] [Abstract][Full Text] [Related]
38. Re-emergence of Chikungunya virus infection in Eastern India.
Sengupta S; Mukherjee S; Haldar SK; Bhattacharya N; Tripathi A
Braz J Microbiol; 2020 Mar; 51(1):177-182. PubMed ID: 31898249
[TBL] [Abstract][Full Text] [Related]
39. Potential Serological Misdiagnosis of Barmah Forest Virus and Ross River Virus Diseases as Chikungunya Virus Infections in Australia: Comparison of ELISA with Neutralization Assay Results.
Kizu J; Graham M; Liu W
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543750
[TBL] [Abstract][Full Text] [Related]
40. High yield expression and purification of Chikungunya virus E2 recombinant protein and its evaluation for serodiagnosis.
Verma A; Chandele A; Nayak K; Kaja MK; Arulandu A; Lodha R; Ray P
J Virol Methods; 2016 Sep; 235():73-79. PubMed ID: 27180040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
